Please login to the form below

academia

This page shows the latest academia news and features for those working in and with pharma, biotech and healthcare.

What exactly do I mean by collaboration? Collaboration with academia to elevate research capabilities.

Novartis and Sanofi heads take on UK pharma leadership roles

world. “In the current Brexit environment, it is more important than ever to collaborate across government, businesses and academia to ensure that the UK can maintain its position as a leader
UCB looks to pipeline with five years left for twin blockbusters

drug discovery partnership with King’s College London university and its research teams working across academia and the NHS.
Merck & Co to buy IO specialists Immune Design for $300m

Big pharma, biotech and academia are zeroing in on a range of immune system mechanisms which could prove crucial to fighting diverse diseases.
UCB signs research deal with King’s College London

our world class expertise in translational research and clinical development at King’s with UCB’s long and successful track record of partnering with UK academia will yield successful benefits for
A genomics and digital-led NHS is possible – but investment in staff essential

It is logical that progress in meeting these challenges will be most effectively addressed through collaboration across industry, NHS and academia.

More from news
Approximately 7 fully matching, plus 135 partially matching documents found.

The science of the deal

There is little empirical evidence for how well these theories, that are well accepted in academia, explain asymmetric R&D deal construction in the unusual, high-uncertainty environment of the life
The search for treatments for Parkinson’s disease

Dr Arthur Roach, director of research at the influential Parkinson’s UK charity, believes that genetic understanding is advancing at pace and that the collaborations between startups, academia, patient groups and ... is ignited by smaller biotechs,
GSK forges ahead with its dynamic COPD and asthma portfolio

But I think the work that we’ve done in collaboration with academia has demonstrated that there are various characteristics, called treatable traits, where you can identify patient groups that are
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

The driver is obviously the economic climate but the number of Chinese scientists returning every year with expertise from US and European academia and institutions is significant,” said Li Xiaofeng, manager
20 for 2020 – Five pharma leaders to watch in 2020

Questions have been raised, however, about his perceived lack of government experience, having spent most of his career in academia, although Hahn insists that isn’t an issue.

More from intelligence
Approximately 1 fully matching, plus 44 partially matching documents found.

New hires at Nanoform, Leo Pharma and Calliditas

Sandler comes to Nanoform with extensive experience in both industry and academia, particularly in pharmaceutical product development and material science.
Kevin Sin joins GSK

Gaining access to the best science and technologies across the world as well as establishing highly productive collaborations with academia and industry, play an important role in creating a world-class
Professor Carole Longson moves from NICE to the ABPI

experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.
Orion appoints VP of oncology, R&D

I hope that my long background in the academia will help in the initiation of new research projects between Orion and the academia.
Storm Therapeutics strengthens its board

I look forward to working with the board to help guide Storm’s innovative research programmes, adding my experience from drug discovery in academia, pharma and biotech.”.

More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.

Covid-19 redefines rules of customer engagement

NHS, as well as regulatory bodies and academia.
Impetus Digital Fireside Chat with Ryan Wiley, President of Shift Health

We also talk about Ryan's shift from academia to consulting and the lessons learned along the way.
Porterhouse Medical Group strengthens its leadership team in the US

She brings a wealth of valuable experience to the Group having held scientific and strategic leadership roles in academia, corporate and global medical communications agencies.
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.

companies as well as associated industries and academia.
Porterhouse Medical Group strengthens its US scientific team

His excellent heritage from academia, through agency, then pharma and back to the consulting and agency world – means that he has an excellent appreciation of client needs and how best an

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Add my company

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Sourcing R&D innovation: why pharma companies need to evolve their business models: Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...